Breaking News - The Fly

Open Search

MNPR

Monopar Therapeutics

$

()

Monopar Therapeutics announces filing of patent protecting MNPR-101

MNPR

4/16/2024 - 08:08am

Monopar Therapeutics just upgraded at JonesResearch, here's why

MNPR

4/11/2024 - 07:25am

Monopar Therapeutics initiates Phase 1 trial for MNPR-101-Zr

MNPR

4/10/2024 - 08:11am

Fly Intel: Pre-market Movers

MNPR , SWAG , ATAI

…

3/28/2024 - 08:59am

Monopar Therapeutics reports Q4 EPS (12c) vs (22c) last year

MNPR

3/28/2024 - 07:02am

Monopar Therapeutics announces preclinical imaging data for MNPR-101

MNPR

3/5/2024 - 07:10am

Monopar Therapeutics provides update on MNPR-101-Zr trial

MNPR

2/27/2024 - 07:09am

Monopar Therapeutics announces preclinical data for its MNPR-101 program

MNPR

2/22/2024 - 07:23am

Monopar receives clearance to proceed with first-in-human trial of MNPR-101-Zr

MNPR

2/20/2024 - 08:06am

Monopar Therapeutics expects cash to fund operations through Nov. 2024

MNPR

11/9/2023 - 07:04am

Monopar Therapeutics reports Q3 EPS (14c), consensus (17c)

MNPR

11/9/2023 - 07:03am

Monopar presents data showing tumor reduction benefit of camsirubicin

MNPR

11/1/2023 - 07:20am

Monopar Therapeutics downgraded to Hold from Buy at JonesResearch

MNPR

8/10/2023 - 11:55am

Monopar Therapeutics reports Q2 EPS (16c), consensus (18c)

MNPR

8/10/2023 - 07:15am

Monopar Therapeutics provides data from Phase 1b trial of camsirubicin

MNPR

8/8/2023 - 07:47am